{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:05:03Z","timestamp":1790888703356,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.contraception.2020.07.001","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T11:26:04Z","timestamp":1594207564000},"page":"262-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pharmacist prescription and access to hormonal contraception for Medicaid-insured women in Oregon"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0465-2586","authenticated-orcid":false,"given":"Susannah E.","family":"Gibbs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Marie","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2020.07.001_b0005","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJMsa1506575","article-title":"Declines in unintended pregnancy in the United States, 2008\u20132011","volume":"374","author":"Finer","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2020.07.001_b0010","unstructured":"Daniels K, Daugherty J, Jones J, Mosher W. Current contraceptive use and variation by selected characteristics among women aged 15-44: United States, 2011-2013. National Health Statistics Reports. 2015:1\u201314."},{"key":"10.1016\/j.contraception.2020.07.001_b0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1363\/psrh.12017","article-title":"Contraceptive failure in the united states: estimates from the 2006\u20132010 national survey of family growth","volume":"49","author":"Sundaram","year":"2017","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.contraception.2020.07.001_b0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1363\/3904807","article-title":"U.S. women's one-year contraceptive use patterns, 2004","volume":"39","author":"Frost","year":"2007","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.contraception.2020.07.001_b0025","unstructured":"National Alliance of State Pharmacy Associations. Pharmacist Prescribing: Hormonal Contraceptives. 2019."},{"key":"10.1016\/j.contraception.2020.07.001_b0030","unstructured":"79th Oregon Legislative Assembly 2017 Regular Session. House Bill 2527. 2017."},{"key":"10.1016\/j.contraception.2020.07.001_b0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1331\/JAPhA.2009.07154","article-title":"Pharmacist interest in and attitudes toward direct pharmacy access to hormonal contraception in the United States","volume":"49","author":"Landau","year":"2009","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.contraception.2020.07.001_b0040","article-title":"Pharmacists' perspectives on prescribing and expanding access to hormonal contraception in pharmacies in the United States","author":"Rafie","year":"2019","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.contraception.2020.07.001_b0045","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/0897190017737897","article-title":"Pharmacist intentions to prescribe hormonal contraception following new legislative authority in California","volume":"32","author":"Vu","year":"2019","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.contraception.2020.07.001_b0050","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1331\/JAPhA.2008.07138","article-title":"Pharmacist prescribing of hormonal contraceptives: results of the Direct Access study","volume":"48","author":"Gardner","year":"2008","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.contraception.2020.07.001_b0055","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1001\/jama.2017.15674","article-title":"Availability of pharmacist-prescribed contraception in California, 2017","volume":"318","author":"Gomez","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2020.07.001_b0060","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/AOG.0000000000002572","article-title":"An evaluation of the implementation of pharmacist-prescribed hormonal contraceptives in California","volume":"131","author":"Batra","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"56","key":"10.1016\/j.contraception.2020.07.001_b0065","first-page":"521","article-title":"Pharmacist prescription of hormonal contraception in Oregon: Baseline knowledge and interest in provision","volume":"2016","author":"Rodriguez","year":"2003","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.contraception.2020.07.001_b0070","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/AOG.0000000000001474","article-title":"Prescription of hormonal contraception by pharmacists in Oregon: Implementation of House Bill 2879","volume":"128","author":"Rodriguez","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2020.07.001_b0075","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.contraception.2019.11.005","article-title":"Availability of pharmacist prescription of contraception in rural areas of Oregon and New Mexico","volume":"101","author":"Rodriguez","year":"2020","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2020.07.001_b0080","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/AOG.0000000000003286","article-title":"Pharmacist provision of hormonal contraception in the oregon medicaid population","volume":"133","author":"Anderson","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2020.07.001_b0085","unstructured":"Office of Population Affairs. Most or Moderately Effective Contraceptive Methods. U.S. Department of Health & Human Services; 2019."},{"key":"10.1016\/j.contraception.2020.07.001_b0090","unstructured":"Office of Health Analytics. CCO Metrics. Oregon Health Authority; 2019."},{"key":"10.1016\/j.contraception.2020.07.001_b0095","unstructured":"United States Census Bureau. ZIP Code Tabulation Areas (ZCTAs). 2020."},{"key":"10.1016\/j.contraception.2020.07.001_b0100","unstructured":"University of Washington. Rural-Urban Community Area Codes (RUCAs). n.d."},{"key":"10.1016\/j.contraception.2020.07.001_b0105","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/AOG.0000000000003265","article-title":"Association of pharmacist prescription of hormonal contraception with unintended pregnancies and medicaid costs","volume":"133","author":"Rodriguez","year":"2019","journal-title":"Obstet Gynecol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782420301876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782420301876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:16:48Z","timestamp":1757881008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782420301876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0010782420301876"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2020.07.001","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacist prescription and access to hormonal contraception for Medicaid-insured women in Oregon","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2020.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}